Aberrant Expression of Multiple T-Cell Markers in Primary Cutaneous Follicle Center Lymphoma: A Rare Case Report.

Authors

V Pfefferle, A Vogelsberg, M Maaß, C M Schürch, S Forchhammer

Published in

Journal of cutaneous pathology. Sep 06, 2026. Epub Sep 06, 2026.

Abstract

Aberrant expression of T-cell markers in B-cell lymphomas is rare and can pose diagnostic challenges. We report a case of a 65-year-old man presenting with newly developed scalp nodules. Histopathology revealed nodular lymphoid infiltrates composed of large centrocytes and centroblasts. Immunohistochemistry demonstrated CD20, BCL6, CD10, and MEF2B positivity with monotypic kappa light chain expression, confirming B-cell lineage. Notably, aberrant co-expression of multiple T-cell markers (CD2, CD3, CD4, and partial CD5), with weaker intensity than surrounding T-cells, was observed. Molecular studies showed clonal immunoglobulin heavy chain rearrangement with a polyclonal T-cell receptor pattern. These findings established the diagnosis of primary cutaneous follicle center lymphoma (PCFCL) with aberrant T-cell marker expression. This represents the first reported case of PCFCL with aberrant expression of multiple T-cell markers, emphasizing the importance of comprehensive immunophenotyping for accurate lymphoma classification.

PMID:
42702564
Bibliographic data and abstract were imported from PubMed on 07 Sep 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.